öÄÀñƼ
öÄÀñƼ£¬¸±½ÌÊÚ£¬Ë¶Ê¿Éúµ¼Ê¦£¬Ò©Ê¹ÜÀí½ÌÑÐÊÒÖ÷ÈΣ¬µÚÆßÅúÈ«¹úÃûÀÏÖÐҽҩר¼ÒѧÊõ¾Ñé¼Ì³Ð¹¤×÷¼Ì³ÐÈË£¬¼æÈιú¼ÊÖÐÒ½Ò©¹æ·¶Ñо¿Ñ§»á£¨GP-TCM RA£©·¨¹æ×éÁªºÏÖ÷ϯ¡¢ÖлªÖÐҽҩѧ»áÖгÉÒ©·Ö»áÇàÄêίԱ¡¢ËÄ´¨Ê¡ÖÐÒ©Ñо¿´Ù½ø»áÒ½Ò©·¨ÂÉÓëÕþ²ßר¼ÒίԱ»áίԱ¡¢¡¶ÖвÝÒ©¡·ÔÓÖ¾ÇàÄê±àίÒÔ¼°Phytomedicine¡¢Chinese medicine¡¢ÖйúÖÐÒ©ÔÓÖ¾µÈ¹úÄÚÍâÆÚ¿¯Éó¸åÈË¡£
½üÄêÀ´Ö÷³Ö¹ú¼ÒÉç»á¿Æѧ»ù½ð¡¢¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð¡¢Öйú²©Ê¿ºó»ù½ð¡¢Ê¡¿Æ¼¼ÌüµÈ¸÷¼¶×ÝÏò¿ÆÑпÎÌâ7ÏÖ÷³ÖÆóҵίÍкáÏò¿ÆÑпÎÌâ3Ï»ñ2020Äê¶ÈÖлªÖÐҽҩѧ»á¿Æѧ¼¼Êõ½±¡¤Õþ²ßÑо¿½±£¨ÅÅÃûµÚ2£©£»ÒÔµÚÒ»»òͨѶ×÷ÕßÔÚ¡¶Pharmacol Res¡·¡¶Phytomedicine¡·¡¶Front. Pharmacol. ¡·¡¶ÖйúÖÐÒ©ÔÓÖ¾¡·¡¶ÖвÝÒ©¡·µÈ¹úÄÚÍâȨÍþÆÚ¿¯·¢±íѧÊõÂÛÎÄ40Óàƪ¡£
Ñо¿·½Ïò£º¢ÙÖÐÒ©¼à¹Ü¿ÆѧÓë¹ú¼Ê»¯Ñо¿£ºÖÂÁ¦ÓÚ¶àѧ¿Æ½»²æÈÚºÏÑо¿£¬Í¨¹ýÖÐҩѧÓë¹ÜÀíѧ¡¢·¨Ñ§µÈÉç»á¿Æѧѧ¿Æ½»²æ£¬¾Û½¹ÎÒ¹úÖÐÒ©È«ÉúÃüÖÜÆÚ¹ÜÀí¡¢Å·ÃÀÖ²ÎïÒ©¼à¹ÜµÈ£¬¿ªÕ¹ÖÐÒ©¼à¹Ü¿ÆѧÓëÖÐÒ©¹ú¼Ê»¯Ñо¿Ì½Ë÷¡£¢ÚÖÐҩЧӦÓë»úÀíÑо¿£ºÍ¨¹ýÖÐҩѧÓë·Ö×ÓÉúÎïѧ¡¢ÉúÎﻯѧµÈѧ¿Æ½»²æ£¬ÒÔÁÙ´²ÐèÇóΪµ¼Ïò£¬¿ªÕ¹ÖÐҩЧӦ¼°»úÀíÑо¿¡£
´ú±íÐÔ¿ÆÑÐÏîÄ¿£º
ÃæÏòÅ·Ã˵ÄÖÐÒ©¹ú¼Ê»¯Ö§³ÖÌåϵ¹¹½¨¼°¡°Öйú»°ÓÑо¿£¨¹ú¼ÒÉç»á¿Æѧ»ù½ð£¬ÔÚÑУ©
»ùÓÚHNF1¦Á/PCSK9/LDLRÐźÅͨ·Ñо¿ÐÄѪ¿µÐͬËûÍ¡Ààҩζ¯ÂöÖàÑùÓ²»¯µÄЧӦ»úÖÆ£¨¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬ÔÚÑУ©
ÒÔÅ·Ã˲ÝҩרÂÛΪÇÐÈëµãµÄÖÐÒ©¹ú¼Ê»¯Ñо¿£¨ËÄ´¨Ê¡¿Æ¼¼ÌüÈí¿ÆѧÑо¿ÏîÄ¿£¬½áÌ⣩
´ú±íÐÔÂÛÎÄ£º
Qu L, Li X, Xiong Y, Wang Z, Zhou Y, Zou W, Tang J, Wang M. Opportunities and hurdles to European market access for multi-herbal traditional Chinese medicine products: An analysis of EU regulations for combination herbal medicinal products. Pharmacol Res. 2022,186:106528. doi: 10.1016/j.phrs.2022.106528
Qu L, Zou W, Wang Y, Wang M. European regulation model for herbal medicine: The assessment of the EU monograph and the safety and efficacy evaluation in marketing authorization or registration in Member States. Phytomedicine. 2018,42:219-225. doi: 10.1016/j.phymed.2018.03.048.
Qu L, Zou W, Zhou Z, Zhang T, Greef J, Wang M. Non-European traditional herbal medicines in Europe: a community herbal monograph perspective. J Ethnopharmacol. 2014,156:107-14. doi: 10.1016/j.jep.2014.08.021.
Qu L, Tan W, Yang J, Lai L, Liu S, Wu J, Zou W. Combination Compositions Composed of l-Glutamine and Si-Jun-Zi-Tang Might Be a Preferable Choice for 5-Fluorouracil-Induced Intestinal Mucositis: An Exploration in a Mouse Model. Front Pharmacol. 2020,11:918. doi: 10.3389/fphar.2020.00918
Li X, Liang J, Qu L*, Liu S, Qin A, Liu H, Wang T, Li W, Zou W*. Exploring the role of ferroptosis in the doxorubicin-induced chronic cardiotoxicity using a murine model. Chem Biol Interact. 2022,363:110008. doi: 10.1016/j.cbi.2022.110008.
öÄÀñƼ, Ìƽ¡Ôª, ÕÅÀÚ, ÑîÖÒÆæ, ԪΨ°², ÍõÍ£, ÕÅÓÀÎÄ, Àî¹¢. ÎÒ¹úÖÐÒ©×¢²á·ÖÀàµÄÀúÊ·Ñݱ䡢ÏÖ×´ÓëÎÊÌâ. ÖйúÖÐÒ©ÔÓÖ¾, 2022, 47(02): 562-568.
öÄÀñƼ, Íõ÷, ×ÞÎÄ¿¡. Å·Ã˲ÝÒ©Ò©Æ·×¢²á¹ÜÀíÏÖ×´ÓëÖÐÒ©Å·ÃË×¢²á²ßÂÔ. ÖвÝÒ©, 2021, 52(20): 6135-6143.
ÓÊÏ䣺quliping@cdutcm.edu.cn